Bleakley Financial Group »

Immunitybio shares owned by Bleakley Financial Group

Quarter-by-quarter ownership of Immunitybio (IBRX) shares owned by Bleakley Financial Group from 13F filings

Historical chart of Bleakley Financial Group investment in Immunitybio

Tip: Access up to 7 years of quarterly data

All positions including Immunitybio held by Bleakley Financial Group consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Immunitybio by Bleakley Financial Group

Quarter filed Position value Share count Share price at filing
2026-03-31 $1.3M 164k 7.67
2024-12-31 $36k 14k 2.56
2024-09-30 $59k 16k 3.72
2024-06-30 $100k 16k 6.32
2024-03-31 $58k 11k 5.37

More positions owned by Bleakley Financial Group

Ishares Tr Core S&p500 Etf (IVV)
Sprott Asset Management Physical Gold An (CEF)
Apple (AAPL)
Ishares Tr Core S&p Mcp Etf (IJH)
Ishares Tr Core S&p Scp Etf (IJR)
Vanguard Index Fds Large Cap Etf (VV)
NVIDIA Corporation (NVDA)
Vanguard Index Fds Mid Cap Etf (VO)
State Str Spdr S&p 500 Etf T Tr Unit (SPY)
Vanguard Index Fds Value Etf (VTV)
Global X Fds 1-3 Month T-bill (CLIP)
Microsoft Corporation (MSFT)
Vanguard Index Fds Growth Etf (VUG)
Ishares Core Msci Emkt (IEMG)
Amazon (AMZN)

View all positions for Bleakley Financial Group

Top funds holding Immunitybio

Vanguard Group
BlackRock
State Street Corporation
Vanguard Portfolio Management
Vanguard Capital Management
D. E. Shaw & Co
Geode Capital Management
Susquehanna International
Citadel Advisors
Two Sigma Investments
LMR Partners
Morgan Stanley
Hrt Financial
Woodline Partners
Goldman Sachs Group

View all funds holding Immunitybio